OMB approves
only the field test, including an incentive experiment, at this
time. No specific incentive structure is pre-approved for the first
wave of PATH (i.e., the baseline for the full study). After the
field test has been completed but before commencing the first wave
of data collection, NIH must submit a non-substantive change that
clearly justifies the structure of incentives, addresses OMB
concerns regarding the wording for some survey items, and otherwise
ensures that the protocol and instruments maximize the utility of
the data collection, minimize burden on participants, avoid
duplication with existing Federal surveys, and comply with HHS data
standards. If NIH plans to make significant changes (e.g., to the
sample design) a full revision may be necessary.
Inventory as of this Action
Requested
Previously Approved
11/30/2015
36 Months From Approved
450,546
0
0
121,572
0
0
0
0
0
The NIH, through NIDA, is partnering
with FDA's newly established Center for Tobacco Products (CTP) in a
large-scale collaboration to conduct the PATH study. This national
longitudinal study of tobacco use and health will provide
epidemiological, population-based data about attitudes and
perceptions related to the use of different existing and emerging
tobacco products; patterns and trends in use of existing and
emerging tobacco products; knowledge of the contents of tobacco
products and of the consequences of their use; and on near- and
longer-term health outcomes associated with tobacco product use.
These data will advance the scientific knowledge base on tobacco
use behaviors and health. In addition, the longitudinal component
will serve to establish a science framework for FDA to track the
potential behavioral and health impacts of specific FSPTCA-related
smoking prevention programs as well as informing the development of
new programs and policies. It will be the only national
longitudinal study of tobacco use. As such, this study provides a
unique opportunity to monitor and assess changes over time in
patterns of use of tobacco products among study respondents. The
study will collect national longitudinal survey data from a cohort
of approximately 59,587 current, former, and never tobacco product
users ages 12 years and older in the U.S. Biospecimens will also be
collected from adult respondents to assess objective measures of
exposure and prospectively monitor indicators of tobacco
use-related harm.
US Code:
42
USC 285o Name of Law: Title 42 USC 285o
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.